Epigenome signature as an immunophenotype indicator prompts durable clinical immunotherapy benefits in lung adenocarcinoma.
Xu PanCaiyu ZhangJunwei WangPeng WangYue GaoShipeng ShangShuang GuoXin LiHui ZhiShangwei NingPublished in: Briefings Bioinform. (2022)
Keyphrases
- lung disease
- lung cancer
- high resolution computed tomography
- lung cancer patients
- signature verification
- clinical trials
- control group
- clinical data
- patient data
- clinical practice
- clinical setting
- computed tomography images
- ct images
- data sets
- medical images
- clinically relevant
- medical treatment
- image registration
- image analysis
- image processing